Cigna's new CEO delivers $71.7B quarter, raises guidance
Plus: J&J cuts 2026 guidance after Firefly Bio buy, Sail Biomedicines option. The day's rules, money, and enforcement, sourced and tiered below.
Plus: J&J cuts 2026 guidance after Firefly Bio buy, Sail Biomedicines option. The day's rules, money, and enforcement, sourced and tiered below.
|
American Health Intel
Rules · Money · Medicine · Decoded daily
|
| The Ledger |
Thursday, July 30, 2026 |
|
|
Cigna's new CEO delivers $71.7B quarter, raises guidance
|
|
Plus: J&J cuts 2026 guidance after Firefly Bio buy, Sail Biomedicines option. The day's rules, money, and enforcement, sourced and tiered below.
|
|
|
Earnings Confidence: High
Cigna, the health insurer and pharmacy benefits giant, posted a $71.7 billion quarter in the first earnings report under its new CEO, beating Wall Street's revenue and profit estimates and raising its full-year guidance.
Revenue hit $71.7 billion, up 7%. Adjusted earnings per share of $7.78 beat estimates. The catch: its medical cost ratio, the share of premiums spent on care, climbed to 84.5% from prior-year risk adjustments in individual plans.
|
Why it matters
This is the first scorecard on Cigna's new CEO, and the numbers came in strong, but watch the medical care ratio for signs of rising costs across the industry.
|
|
|
Deal Confidence: High
Johnson & Johnson, the drugmaker behind Stelara and Darzalex, cut its own 2026 profit forecast today after completing a $1 billion buyout of an oncology biotech and taking an option on a second one focused on autoimmune disease.
The combined Firefly Bio and Sail Biomedicines deals will cut adjusted earnings per share by about 64 cents this year. Sail's technology reprograms immune cells inside the body without lab-grown cell manufacturing.
|
Why it matters
J&J chose to absorb a near term profit hit to buy into next-generation cancer and autoimmune disease technology, a bet that the science pays off later even as this year's numbers take a hit.
|
|
|
Also today
Ventas nearly doubles senior housing investment target to $4.5B Read
UHealth and UnitedHealthcare down to 1 day before deadline Read
Included Health acquires Firefly Health to scale alternative health plans Read
FRONTIER SCAN: Grifols posts profit growth while closing US donor centers Read
|
318 Records | $19.6B Enforcement | 15 Deadlines | 95 Rules |
|
|
Pick your field on the site and every story tells you what it means for you.
|
|
Reply to this email and tell us what you want covered. We read everything.
|
|
We show our work. We score our own calls.
News and analysis, not legal, medical, coding, or investment advice.
You subscribed at americanhealthintel.com · Unsubscribe
|
|